Concentration and drug prices in the retail market for malaria treatment in rural Tanzania

Health Economics

Volumn 18, Issue 6, 2009, Pages 727-742

  Goodman, Catherine ^a,b   Kachur, S Patrick ^c   Abdulla, Salim ^d   Bloland, Peter ^e   Mills, Anne ^a  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b KEMRI WELLCOME TRUST RESEARCH PROGRAMME   (Kenya)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^d IFAKARA HEALTH INSTITUTE   (Tanzania)

^e NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

Author keywords

Competition; Malaria; Markets; Pharmaceuticals; Retail sector

Indexed keywords

AMODIAQUINE; CHLOROQUINE; FANSIDAR; METAKELFIN; QUININE; ANTIMALARIAL AGENT;

ARTICLE; COMMERCIAL PHENOMENA; CONSUMER; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DRUG COST; DRUG MARKETING; DRUG QUALITY; DRUG UTILIZATION; ECONOMIC EVALUATION; GEOGRAPHIC DISTRIBUTION; HEALTH CARE POLICY; HEALTH ECONOMICS; HUMAN; MALARIA; ORGANIZATION AND MANAGEMENT; PRIORITY JOURNAL; RESOURCE MANAGEMENT; RURAL AREA; TANZANIA; ECONOMIC ASPECT; ECONOMICS; HEALTH CARE COST; INFORMATION PROCESSING; RURAL POPULATION;

ANTIMALARIALS; COMMERCE; DATA COLLECTION; ECONOMIC COMPETITION; HEALTH EXPENDITURES; HUMANS; MALARIA; RURAL POPULATION; TANZANIA;

EID: 68849086742     PISSN: 10579230     EISSN: 10991050     Source Type: Journal    
DOI: 10.1002/hec.1473     Document Type: Article

References (57)

1. Amin MA. 2002. An analysis of private hospital markets in Bangladesh. Ph.D. Thesis, Department of Public Health and Policy, London School of Hygiene and Tropical Medicine, University of London.
2. Ashton T, Press D. 1997. Market concentration in secondary health services under a purchaser-provider split: the New Zealand experience. Health Economics 6(1): 43-56.
3. Baumol WJ, Panzar JC, Willig RD. 1982. Contestable Markets and the Theory of Industry Structure. Harcourt Brace Jovanovich, Inc.: San Diego and New York.
4. Bennett S. 1996. Imperfect information and hospital competition in developing countries: a Bangkok case study. Ph.D. Thesis, Department of Public Health and Policy, London School of Hygiene and Tropical Medicine, University of London.
5. Bennett S, Quick JD, Velásquez G. 1997. Public-private roles in the pharmaceutical sector: implications for equitable access and rational drug use. Health Economics and Drugs DAP Series No. 5, WHO/DAP/ 97.12. World Health Organisation, Action Programme on Essential Drugs, Geneva.
6. Berman P. 2000. Organization of ambulatory care provision: a critical determinant of health system performance in developing countries. Bulletin of the World Health Organization 78(6): 791-802.
7. Bosman A, Mendis KN. 2007. A major transition in malaria treatment: the adoption and deployment of artemisinin-based combination therapies. American Journal of Tropical Medicine and Hygiene 77(6 Suppl): 193-197.
8. Brugha R, Chandramohan D, Zwi A. 1999. Viewpoint: management of malaria - working with the private sector. Tropical Medicine and International Health 4(5): 402-406.
9. Brugha R, Zwi AB. 1999. Sexually transmitted disease control in developing countries: the challenge of involving the private sector. Sexually Transmitted Infections 75(5): 283-285.
10. Chirikos TN. 1992. Quality competition in local hospital markets: some econometric evidence from the period 1982-1988. Social Science & Medicine 34(9): 1011-1021.
11. Clarke R. 1985. Industrial Economics. Blackwell Publishers Inc.: Massachusetts.
12. Clinton Foundation and Government of Tanzania. 2007. Tanzania Pilot ACT Subsidy: Report on Preliminary Findings, November 2007.
13. Conteh L, Hanson K. 2003. Methods for studying private sector supply of public health products in developing countries: a conceptual framework and review. Social Science & Medicine 57(7): 1147-1161.
14. D'Alessandro U, Talisuna A, Boelaert M. 2005. Editorial: should artemisinin-based combination treatment be used in the home-based management of malaria? Tropical Medicine & International Health 10(1): 1-2.
15. de Savigny D, Mayombana C, Mwageni E, Masanja H, Minhaj A, Mkilindi Y et al. 2004. Care-seeking patterns for fatal malaria in Tanzania. Malaria J 3(1): 27.
16. Demsetz H. 1973. The Market Concentration Doctrine: AEI-Hoover Policy Studies.
17. Dranove D, Satterthwaite MA. 2000. The industrial organization of health care markets. In Handbook of Health Economics, Culyer AJ, Newhouse JP (eds). Elsevier Science: Amsterdam; 1094-1139.
18. Enserink M. 2007. Combating malaria. Malaria treatment: ACT two. Science 318(5850): 560-563.
19. Fafchamps M. 1994. Industrial structure and microenterprises in Africa. The Journal of Developing Areas 29: 1-30.
20. Filmer D, Pritchett L. 2001. Estimating wealth effects without expenditure data - or tears: with an application to educational enrollements in states of India. Demography 38(1): 115-132.
21. Gaynor M, Vogt WB. 2000. Antitrust and competition in health care markets. In Handbook of Health Economics, Culyer AJ, Newhouse JP (eds). vol. I. Elsevier Science B.V.: Amsterdam.
22. Ginson-Bautista MC. 1995. Markets in health care: an analysis of demand, supply and the market structure of health care in the Philippines. Ph.D. Thesis, Department of Public Health and Policy, London School of Hygiene and Tropical Medicine.
23. Goodman C, Brieger W, Unwin A, Mills A, Meek S, Greer G. 2007a. Medicine sellers and malaria treatment in sub-Saharan Africa: what do they do and how can their practice be improved? American Journal of Tropical Medicine and Hygiene 77(6 Suppl): 203-218.
24. Goodman C, Kachur SP, Abdulla S, Bloland P, Mills A. 2007b. Drug shop regulation and malaria treatment in Tanzania - why do shops break the rules, and does it matter? Health Policy Plan 22(6): 393-403.
25. Goodman C, Kachur SP, Abdulla S, Mwageni E, Nyoni J, Schellenberg JA et al. 2004. Retail supply of malaria-related drugs in rural Tanzania: risks and opportunities. Tropical Medicine & International Health 9(6): 655-663.
26. Goodman CA. 2004. An economic analysis of the retail market for fever and malaria treatment in rural Tanzania. Ph.D. Thesis, Department of Public Health and Policy, London School of Hygiene and Tropical Medicine, University of London.
27. Greenwood BM, Bradley AK, Greenwood AM, Byass P, Jammeh K, Marsh K, et al. 1987. Mortality and morbidity from malaria among children in a rural area of The Gambia, West Africa. Transactions of the Royal Society of Tropical Medicine and Hygiene 81(3): 478-486.
28. Institute of Medicine. 2004. Saving Lives, Buying Time: Economics of Malaria Drugs in an Age of Resistance. National Academies Press: Washington, DC.
29. Luft HS, Maerki SC. 1984. The competitiveness of hospital markets. Contemporary Policy Issues 3(2): 89-102.
30. Malaria Consortium. 2004. Tanzania Roll Back Malaria Consultative Mission (Reaping): Essential Actions to Support the Attainment of the Abuja Targets, London.
31. McCombie SC. 2002. Self-treatment for malaria: the evidence and methodological issues. Health Policy Plan 17(4): 333-344.
32. McKenzie DJ. 2003. Measuring inequality with asset indicators. BREAD Working Paper No. 042, Bureau for Research in Economic Analysis of Development, Stanford, CA.
33. Mills A, Brugha R, Hanson K, McPake B. 2002. What can be done about the private health sector in low-income countries? Bulletin of the WHO 80(4): 325-330.
34. Munishi GK, Yazbeck A, Deroeck S, Lionetti D. 1995. Private sector delivery of health care in Tanzania. Bethesda, MD. Major Applied Research Paper No. 14, Health Financing and Sustainability Project, Abt Assoicates Inc.
35. Muraleedharan VR. 1999. Characteristics and Structure of the Private Hospital Sector in Urban India: A Case Study of Madras City. Indian Instiute of Technology: Madras, India.
36. Nakamba P, Hanson K, McPake B. 2002. Markets for hospital services in Zambia. International Journal of Health Planning and Management 17(3): 229-247.
37. National Malaria Control Programme. 2003. Malaria Medium Term Strategic Plan 2002-2007 in Tanzania; Implementation and Achievement 2003, Ministry of Health, Dar es Salaam, Tanzania.
38. Njau JD, Goodman C, Kachur SP, Palmer N, Khatib RA, Abdulla S et al. 2006. Fever treatment and household wealth: the challenge posed for rolling out combination therapy for malaria. Tropical Medicine & International Health 11(3): 299-313.
39. Owen F, Jones R. 1990. Statistics. Pitman Publishing: London.
40. Propper C, Soderlund N. 1998. Competition in the NHS internal market: an overview of its effects on hospital prices and costs. Health Economics 7(3): 187-197.
41. Roberts JA. 1993. Managing markets. Journal of Public Health Medicine 14(4): 305-310.
42. Robinson J, Luft H. 1987. Competition and the cost of hospital care - 1972-1982. Journal of the American Medical Association 257(23): 3241-3245.
43. Robinson JC, Luft HS, McPhee SJ, Hunt S. 1988. Hospital competition and surgical length of stay. Journal of the American Medical Association 259(5): 696-700.
44. Scherer FM. 1970. Industrial Market Structure and Economic Performance. Rand McNally: Chicago.
45. Stata Inc. 2003. Survey Data Reference Manual. Stata Press: College Station, TX.
46. Tirole J. 1988. The Theory of Industrial Organisation. The MIT Press: Cambridge, MA.
47. Tripp AM. 2003. Non-formal institutions, informal economies and the politics of inclusion. In Reforming Africa's Institutions - Ownership, Incentives, and Capabilities. Kayizzi-Mugerwa S (ed.). United Nations University Press: Tokyo, Japan.
48. Uplekar M, Juvekar S, Morankar S, Rangan S, Nunn P. 1998. Tuberculosis patients and practitioners in private clinics in India. International Journal of Tuberculosis and Lung Disease 2(4): 324-329.
49. Waters H, Hatt L, Peters D. 2003. Working with the private sector for child health. Health Policy Plan 18(2): 127-137.
50. Waterson M. 1984. Economic Theory of the Industry. Cambridge University Press: Cambridge.
51. White NJ, Nosten F, Looareesuwan S, Watkins WM, Marsh K, Snow RW et al. 1999. Viewpoint: averting a malaria disaster. The Lancet 353: 1965-1967.
52. WHO. 2004. Scaling up Home-based Management of Malaria. Roll Back Malaria Department/UNICEF/UNDP/World Bank/TDRWHO/HTM/MAL/2004.1096, Geneva.
53. WHO. 2005. The Roll Back Malaria Strategy for Improving Access to Treatment through Home Management. WHO/HTM/MAL/2005.1101, Geneva.
54. Williams HA, Jones CO. 2004. A critical review of behavioral issues related to malaria control in sub-Saharan Africa: what contributions have social scientists made? Social Science & Medicine 59(3): 501-523.
55. Wilson GW, Jadlow JM. 1982. Competition, profit incentives, and technical efficiency in the provision of nuclear medicine services. Bell Journal of Economics 13: 472-482.
56. World Bank. 2008.World Development Indicators online - http://web.worldbank.org/, Accessed 29/2/08.
57. Zwanziger J, Melnick G, Eyre KM. 1994. Hospitals and antitrust: defining markets, setting standards. Journal of Health Politics Policy and Law 19(2): 423-447.